[S-10] S-10: Progress of TDM for hematopoietic stem cell transplantation

[S-10-2] Therapeutic drug monitoring (TDM) in paediatric and adult patients on high dose busulfan conditioning therapy: a retrospective analysis including outcomes

Hundie Tesfaye¹, Eva Klapkova², Romana Pospisilova³, Richard Prusa⁴, Petr Riha⁵, Renata Formankova⁶, Daniela Janeckova⁷, Petr Sedlacek⁸, Petra Keslova⁹, Josef Malis¹⁰, Ludmila Novakova¹¹, Jan Vydra¹² (1.University Hospital in Motol, 2nd Faculty of Medicine, Charles University, 2.University Hospital in Motol, Charles University, 3.University Hospital in Motol, Charles University, 4.University Hospital in Motol, Charles University, 5.University Hospital in Motol, Charles University, 6.University Hospital in Motol, Charles University, 7.University Hospital in Motol, Charles University, 8.University Hospital in Motol, Charles University, 9.University Hospital in Motol, Charles University, 10.University Hospital in Motol, Charles University, 11.Institue of Haematology and Blood Transfusion, 12.Institue of Haematology and Blood Transfusion)

Keywords:TDM, Busulfan, Dose/AUC Paediatric/Adult, HSCT Outcomes